L413-0091 Screening compound: N-[(3-methoxyphenyl)methyl]-4-(1-propanoyl-2,3-dihydro-1H-indol-5-yl)benzamide

L413-0091 Screening compound: N-[(3-methoxyphenyl)methyl]-4-(1-propanoyl-2,3-dihydro-1H-indol-5-yl)benzamide
L413-0091 Screening compound: N-[(3-methoxyphenyl)methyl]-4-(1-propanoyl-2,3-dihydro-1H-indol-5-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L413-0091
N-[(3-methoxyphenyl)methyl]-4-(1-propanoyl-2,3-dihydro-1H-indol-5-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L413-0091

Molecular Formula

C26H26N2O3 (C26 H26 N2 O3)

Compound Name

N-[(3-methoxyphenyl)methyl]-4-(1-propanoyl-2,3-dihydro-1H-indol-5-yl)benzamide

IUPAC name

N-[(3-methoxyphenyl)methyl]-4-(1-propanoyl-23-dihydro-1H-indol-5-yl)benzamide

SMILES

CCC(N(CC1)c(cc2)c1cc2-c(cc1)ccc1C(NCc1cc(OC)ccc1)=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

414.5

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.669

Distribution Coefficient, logD

4.669

Water Solubility, LogSw

-4.37

Polar Surface Area

47.347

Acid Dissociation Constant (pKa)

12.28

Base Dissociation Constant (pKb)

-0.59

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.10

L413-0091 in Drug Discovery

Included in Screening Libraries

Bromodomain Modulators Library (5801 compounds)

Lipid Metabolism Library (9174 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Metabolic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L413-0091 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L413-0091?
Check Price and Availability of L413-0091, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L413-0091 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L413-0091
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L413-0091
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L413-0091 available by request